4.4 Article

Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT)

期刊

TRIALS
卷 15, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1745-6215-15-136

关键词

Cardiovascular diseases; Metabolic syndrome; Plasma fatty acids; Serum lipids; Lipoproteins; Canola oil; DHA; Randomized controlled clinical trial

资金

  1. Canola Council of Canada through the Growing Forward program of Agriculture and Agri-Food Canada
  2. Flax Council of Canada through the Growing Forward program of Agriculture and Agri-Food Canada
  3. Agriculture and Agri-Food Canada through the Growing Forward program of Agriculture and Agri-Food Canada
  4. Dow Agrosciences through the Growing Forward program of Agriculture and Agri-Food Canada
  5. Canada Research Chairs through the Growing Forward program of Agriculture and Agri-Food Canada
  6. Western Grains Research Foundation through the Growing Forward program of Agriculture and Agri-Food Canada
  7. National Center for Research Resources [UL1 RR033184]
  8. National Center for Advancing Translational Sciences [UL1 TR000127]

向作者/读者索取更多资源

Background: The Canola Oil Multicenter Intervention Trial (COMIT) was a randomized controlled crossover study designed to evaluate the effects of five diets that provided different oils and/or oil blends on cardiovascular disease (CVD) risk factors in individuals with abdominal obesity. The present objective is to report preliminary findings on plasma fatty acid profiles in volunteers with abdominal obesity, following the consumption of diets enriched with n-3, n-6 and n-9 fatty acids. Methods: COMIT was conducted at three clinical sites, Winnipeg, Manitoba, Canada, Quebec City, Quebec, Canada and University Park, Pennsylvania, United States. Inclusion criteria were at least one of the followings: waist circumference (>= 90 cm for males and >= 84 cm for females), and at least one other criterion: triglycerides >= 1.7 mmol/L, high density lipoprotein cholesterol < 1 mmol/L (males) or <1.3 mmol/L (females), blood pressure >= 130 mmHg (systolic) and/or >= 85 mmHg (diastolic), and glucose >= 5.5 mmol/L. Weight-maintaining diets that included shakes with one of the dietary oil blends were provided during each of the five 30-day dietary phases. Dietary phases were separated by four-week washout periods. Treatment oils were canola oil, high oleic canola oil, high oleic canola oil enriched with docosahexaenoic acid (DHA), flax oil and safflower oil blend, and corn oil and safflower oil blend. A per protocol approach with a mixed model analysis was decided to be appropriate for data analysis. Results: One hundred and seventy volunteers were randomized and 130 completed the study with a dropout rate of 23.5%. The mean plasma total DHA concentrations, which were analyzed among all participants as a measure of adherence, increased by more than 100% in the DHA-enriched phase, compared to other phases, demonstrating excellent dietary adherence. Conclusions: Recruitment and retention strategies were effective in achieving a sufficient number of participants who completed the study protocol to enable sufficient statistical power to resolve small differences in outcome measures. It is expected that the study will generate important data thereby enhancing our understanding of the effects of n-3, n-6, and n-9 fatty acid-containing oils on CVD risks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据